Should infliximab be used as an adjuvant to IVIG in the treatment of children with kawasaki disease who are at high risk for resistance to conventional therapy?

Shelby Davies, Gabrielle Gold-Von Simson

Research output: Contribution to journalLetter

7 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalPediatric Cardiology
Volume34
Issue number7
DOIs
StatePublished - Oct 1 2013

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this